ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)

Pharmasoft · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
glaucomamitochondrial-dysfunctionneuroprotection
primary open-angle glaucoma (poag), glaucoma, glaucomatous optic neuropathy (gon), mitochondrial dysfunction, neuroprotection, retiniprotection, mexidol, ethylmethylhydroxypyridine succinate, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 846133
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.